1. Home
  2. FMY vs ECOR Comparison

FMY vs ECOR Comparison

Compare FMY & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Motgage Income Fund of Beneficial Interest

FMY

First Trust Motgage Income Fund of Beneficial Interest

HOLD

Current Price

$12.12

Market Cap

51.7M

Sector

Finance

ML Signal

HOLD

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$6.16

Market Cap

52.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMY
ECOR
Founded
2005
2005
Country
United States
US
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.7M
52.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
FMY
ECOR
Price
$12.12
$6.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.00
AVG Volume (30 Days)
3.6K
60.6K
Earning Date
01-01-0001
04-11-2026
Dividend Yield
6.98%
N/A
EPS Growth
N/A
53.51
EPS
N/A
N/A
Revenue
N/A
$25,182,000.00
Revenue This Year
N/A
$28.92
Revenue Next Year
N/A
$32.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
57.09
52 Week Low
$11.65
$4.16
52 Week High
$12.39
$19.49

Technical Indicators

Market Signals
Indicator
FMY
ECOR
Relative Strength Index (RSI) 50.02 52.07
Support Level $12.06 $5.15
Resistance Level $12.18 $6.89
Average True Range (ATR) 0.08 0.61
MACD -0.00 -0.04
Stochastic Oscillator 66.67 43.85

Price Performance

Historical Comparison
FMY
ECOR

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: